ICON Public (NASDAQ:ICLR – Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided EPS guidance of $14.65-$15.15 for the period, compared to the consensus EPS estimate of $14.94. The company issued revenue guidance of $8.48-$8.72 billion, compared to the consensus revenue estimate of $8.64 billion.
Analysts Set New Price Targets
A number of research analysts have recently commented on the company. Mizuho reiterated a buy rating and issued a $346.00 price target on shares of ICON Public in a research note on Thursday, April 4th. Evercore ISI increased their price target on ICON Public from $325.00 to $350.00 and gave the company an outperform rating in a research note on Friday, February 23rd. Robert W. Baird increased their price objective on ICON Public from $345.00 to $362.00 and gave the company an outperform rating in a report on Thursday, April 4th. Barclays increased their price objective on ICON Public from $325.00 to $355.00 and gave the company an overweight rating in a report on Friday, February 23rd. Finally, Truist Financial increased their price objective on ICON Public from $357.00 to $367.00 and gave the company a buy rating in a report on Friday, February 23rd. One equities research analyst has rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat, ICON Public has a consensus rating of Moderate Buy and an average target price of $319.45.
Read Our Latest Analysis on ICON Public
ICON Public Trading Down 2.9 %
ICON Public (NASDAQ:ICLR – Get Free Report) last issued its quarterly earnings results on Wednesday, February 21st. The medical research company reported $3.40 earnings per share for the quarter, topping analysts’ consensus estimates of $3.27 by $0.13. ICON Public had a return on equity of 11.42% and a net margin of 7.54%. The firm had revenue of $2.07 billion during the quarter, compared to the consensus estimate of $2.08 billion. Research analysts predict that ICON Public will post 14.4 earnings per share for the current year.
About ICON Public
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.
Further Reading
- Five stocks we like better than ICON Public
- What is the Dow Jones Industrial Average (DJIA)?
- Hasbro’s Management Made All the Right Calls This Quarter
- Most Volatile Stocks, What Investors Need to Know
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- How to Calculate Inflation Rate
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for ICON Public Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICON Public and related companies with MarketBeat.com's FREE daily email newsletter.